DOD – Vision Research Program (VRP) – Application
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with unit
Memorial Deadline: Friday 6th, November 2026
External Deadline: Thursday 12th, November 2026
Description
Clinical Trial Award
The VRP CTA supports the rapid implementation of clinical trials with the potential to have a
significant impact on the treatment or management of service-connected eye injury and visual
dysfunction. Clinical trials may be designed to evaluate promising new products, pharmacologic
agents (drugs, biologics or medical devices), clinical guidance and/or emerging approaches and
technologies. Proposed projects may range from small proof-of-concept trials (i.e., pilot, first-inhuman, phase 0) to demonstrate the feasibility or inform the design of more advanced trials
through large-scale trials to determine efficacy in relevant patient populations.
Investigator-Initiated Research Award
The VRP IIRA supports basic to early translational studies that will yield highly impactful
discoveries or major advancements in the research and/or patient care of eye injury and/or
visual dysfunction as related to military exposure.
The IIRA may be used to support preclinical studies and/or clinical research. However, the IIRA
may not be used to conduct clinical trials.
Translational Research Award
The VRP TRA supports translational research that transforms a promising discovery into new
drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials
during or by the end of the period of performance.
The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial
(PCT). Applications proposing a PCT must also include non-PCT, translational research
component(s) (e.g., preclinical studies, clinical research).
To view the VRP funding opportunity announcements and submit a pre-application, visit
https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719107
Pre-Application Due: July 28, 2026
Application Due: November 12, 2026